Found: 21
Select item for more details and to access through your institution.
α4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 110, n. 5, p. 1123, doi. 10.1002/jcb.22624
- By:
- Publication type:
- Article
ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 16, p. 1236, doi. 10.1093/jnci/djr256
- By:
- Publication type:
- Article
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.
- Published in:
- Oncogene, 2003, v. 22, n. 32, p. 5070, doi. 10.1038/sj.onc.1206775
- By:
- Publication type:
- Article
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 908, doi. 10.1038/s41416-022-01806-6
- By:
- Publication type:
- Article
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 482, doi. 10.1038/s41416-021-01538-z
- By:
- Publication type:
- Article
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
- Published in:
- 2021
- By:
- Publication type:
- journal article
ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00178
- By:
- Publication type:
- Article
The RNA‐helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 4, p. 1162, doi. 10.1002/1878-0261.12906
- By:
- Publication type:
- Article
A xenograft model of infant leukaemia reveals a complex MLL translocation.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race?
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28945
- By:
- Publication type:
- Article
ABC transporters in cancer: more than just drug efflux pumps.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer.
- Published in:
- JNCI Cancer Spectrum, 2018, v. 2, n. 3, p. 1, doi. 10.1093/jncics/pky047
- By:
- Publication type:
- Article
Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.779859
- By:
- Publication type:
- Article
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-12971-3
- By:
- Publication type:
- Article
Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1878, doi. 10.3390/cancers14081878
- By:
- Publication type:
- Article
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1807, doi. 10.3390/cancers13081807
- By:
- Publication type:
- Article
FDA-approved disulfiram as a novel treatment for aggressive leukemia.
- Published in:
- Journal of Molecular Medicine, 2024, v. 102, n. 4, p. 507, doi. 10.1007/s00109-023-02414-4
- By:
- Publication type:
- Article
Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 7, p. 1902, doi. 10.1002/ijc.32582
- By:
- Publication type:
- Article